Related Experiment Videos
[Adrenomedullin in cardiovascular pathology]
Emanuela Piroli1, Claudia Annoscia, Francesco Ranieri
1V Clinica Medica, Dipartimento di Fisiopatologia Medica, Policlinico Umberto I, Università La Sapienza, Roma.
Recenti Progressi in Medicina
|May 18, 2004
Summary
Adrenomedullin (AM) lowers blood pressure by dilating blood vessels, showing potential for cardiovascular conditions. Elevated AM levels in heart failure and hypertension suggest its role in disease progression.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
Context:
- Adrenomedullin (AM) is a peptide hormone with significant vasodilatory properties.
- It is produced by various cell types, including vascular endothelial and smooth muscle cells.
- Elevated plasma AM levels are observed in cardiovascular diseases such as heart failure and hypertension.
Purpose:
- To explore the cardiovascular actions of Adrenomedullin.
- To investigate the potential role of AM in the pathophysiology of cardiovascular diseases.
Summary:
- Adrenomedullin (AM) exhibits potent hypotensive activity through the dilation of resistance blood vessels.
- AM is synthesized and secreted by multiple cell types, notably vascular endothelial and smooth muscle cells.
- Increased circulating AM levels are associated with conditions like heart failure and hypertension, indicating its involvement in disease mechanisms.
Impact:
- Understanding Adrenomedullin's role can offer new therapeutic targets for cardiovascular diseases.
- Further research into AM may elucidate its contribution to the progression of heart failure and hypertension.
- This peptide's vasodilatory effects highlight its importance in regulating vascular tone and blood pressure.